LIM
PROF

Lagoda Investment Management’s Profound Medical PROF Stock Holding History

Lagoda Investment Management’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.33M Buy
501,325
+60,310
+14% +$405K 1.83% 18
2026
Q1 		$2.86M Buy
+441,015
New +$3.05M 1.76% 17

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Lagoda Investment Management's PROF Position: Q2 2026 in Review

Lagoda Investment Management increased its Profound Medical (PROF) stake by 14% in Q2 2026, buying an estimated $405K and bringing the position to 501,325 shares worth $3.33M. The position accounts for 1.83% of the portfolio, ranked #18.

Lagoda Investment Management first reported a position in PROF in Q1 2026 and has held it in 2 quarters since. 56 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • Lagoda Investment Management held 501,325 shares of Profound Medical worth $3.33M as of Q2 2026.
  • Lagoda Investment Management bought 60,310 Profound Medical shares in Q2 2026, an estimated $405K.
  • Profound Medical made up 1.83% of Lagoda Investment Management's portfolio in Q2 2026, its #18 holding.
  • Lagoda Investment Management first reported a position in Profound Medical in Q1 2026 and has held it in 2 quarters since.
  • 56 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Lagoda Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.